Immediate Impact

1 by Nobel laureates 4 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Crohn's disease
2024 Standout
3 intermediate papers

Works of Andrea Bedynek being referenced

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
2013

Author Peers

Author Last Decade Papers Cites
Andrea Bedynek 277 278 57 171 10 702
Björn Hammarskjöld 177 139 146 111 8 706
Ferdinand M. van’t Hooft 301 122 14 162 19 736
Mounzer Soued 107 93 16 148 12 710
Virginia Nguyen 168 92 17 114 13 756
Yared Gurmu 202 170 39 33 17 668
S. D. Mohamed 241 145 64 38 16 694
Rosemarijn Renckens 62 125 44 190 14 723
Michelle R. Joshi 309 210 16 98 8 585
Irina Movsesyan 255 225 11 35 18 595
Martha Hernandez‐Illas 219 146 97 106 20 765

All Works

Loading papers...

Rankless by CCL
2026